Back to SILVERCREST ASSET MANAGEMENT GROUP LLC SILVERCREST ASSET MANAGEMENT GROUP LLC

DRNADRNA
7 quarters

Position history for SILVERCREST ASSET MANAGEMENT GROUP LLCSILVERCREST ASSET MANAGEMENT GROUP LLC's holdings in DICERNA PHARMACEUTICALS INC

SILVERCREST ASSET MANAGEMENT GROUP LLC previously held 0 shares of DRNA (DICERNA PHARMACEUTICALS INC), worth $0 as of 2021-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$2.2M

Total Shares Change

-87,460

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q4
Latest
Exited
0
-100.0%
$00.0%
0
2021-Q3
Increased
180,502
+22.9%
$3.6M0.0%
32
2021-Q2
Decreased
146,816
-0.2%
$5.5M0.0%
0
2021-Q1
Decreased
147,108
-11.2%
$3.8M0.0%
0
2020-Q4
Decreased
165,728
-13.8%
$3.7M0.0%
0
2020-Q3
Increased
192,205
+119.8%
$3.5M0.0%
43
2020-Q2
New
87,460
-
$2.2M0.0%
36

Other major holders of DRNA: RTW INVESTMENTS, LP, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used